Hormonal Circadian Rhythms in Patients with Congenital Adrenal Hyperplasia: Identifying Optimal Monitoring Times and Novel Disease Biomarkers

OBJECTIVES: The treatment goal in congenital adrenal hyperplasia (CAH) is to replace glucocorticoids while avoiding androgen excess and iatrogenic Cushing’s syndrome. However, there is no consensus on how to monitor disease control. Our main objectives were to evaluate hormonal circadian rhythms and...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Eur J Endocrinol
Asıl Yazarlar: Debono, Miguel, Mallappa, Ashwini, Gounden, Verena, Nella, Aikaterini A, Harrison, Robert F, Crutchfield, Christopher A, Backlund, Peter S, Soldin, Steven J, Ross, Richard J, Merke, Deborah P
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2015
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4623929/
https://ncbi.nlm.nih.gov/pubmed/26340969
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1530/EJE-15-0064
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller